The FDA has determined it to be bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon Laboratories Inc. Olopatadine Hydrochloride Ophthalmic Solution USP ...

1 Glenmark's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the indications listed in Glenmark's approved drug facts label. 2 This product is not manufactured ...

Roshni Nadar Malhotra has cemented her place as India's third-richest individual following a major succession move within the HCL Group. She received 47% of her father Shiv Nadar's stake in HCL ...

In the Treasury market, yields have declined as investors purchase bonds. The shorter-end U.S. 2-Year Treasury yield (US2Y) fell by 8 basis points to 3.91%. Meanwhile, the longer-end U.S. 10-Year ...

Lidocaine hydrochloride (HCl) 2% jelly may offer a more accessible alternative to lidocaine-prilocaine cream for reducing pain during pessary maintenance, but its effectiveness remains untested.